More than skin deep: atherosclerosis as a systemic manifestation of psoriasis

被引:115
作者
Alexandroff, A. B. [1 ]
Pauriah, M. [2 ]
Camp, R. D. R. [3 ]
Lang, C. C. [2 ]
Struthers, A. D. [2 ]
Armstrong, D. J. [4 ]
机构
[1] Leicester Royal Infirm, Dept Dermatol, Leicester LE1 5WW, Leics, England
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol, Div Med & Therapeut, Dundee DD1 9SY, Scotland
[3] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England
[4] Altnagelvin Hosp, Dept Rheumatol, Londonderry, North Ireland
关键词
atherosclerosis; cardiovascular disease; metabolic syndrome; psoriasis; tumour necrosis factor-alpha; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; CORONARY-ARTERY-DISEASE; EVIDENT CARDIOVASCULAR-DISEASE; PLACEBO-CONTROLLED TRIAL; TOLL-LIKE-RECEPTORS; RHEUMATOID-ARTHRITIS; RISK-FACTORS; MYOCARDIAL-INFARCTION; ENDOTHELIAL FUNCTION;
D O I
10.1111/j.1365-2133.2009.09281.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
There is now growing evidence that psoriasis, like other inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus, is a systemic disorder that is associated with enhanced atherosclerosis and risk of coronary artery disease. Here we summarize the available epidemiological evidence for this association and analyse pathogenic features that are common to psoriasis and atherosclerosis. Further prospective studies are urgently needed to extend knowledge of the risk of cardiovascular morbidity and mortality in patients with psoriasis and to confirm the degree to which treatment of psoriasis reduces this risk. Nevertheless, existing data are sufficient to indicate that severe psoriasis should be more widely recognized as a potential risk factor for cardiovascular disease and should be considered with the established factors when formulating strategies for the management of cardiovascular risk.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 126 条
[11]  
Brodmerkel C, 2008, BRIT J DERMATOL, V159, P1425
[12]  
Bruce A, 2008, BRIT J DERMATOL, V159, P1396
[13]   'Not only ... but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus [J].
Bruce, IN .
RHEUMATOLOGY, 2005, 44 (12) :1492-1502
[14]   Premature atherosclerosis in systemic lupus erythematosus [J].
Bruce, IN ;
Gladman, DD ;
Urowitz, MB .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2000, 26 (02) :257-+
[15]   IL-20 and atherosclerosis another brick in the wall [J].
Caligiuri, Giuseppina ;
Kaveri, Srini V. ;
Nicoletti, Antonino .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (09) :1929-1930
[16]   Serum leptin levels, skin leptin and leptin receptor expression in psoriasis [J].
Cerman, A. A. ;
Bozkurt, S. ;
Sav, A. ;
Tulunay, A. ;
Elbasi, M. O. ;
Ergun, T. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (04) :820-826
[17]   Dynamic frequency of CD4+CD25+Foxp3+ treg cells in psoriasis vulgaris [J].
Chen, Ling ;
Shen, Zhu ;
Wang, Gang ;
Fan, Pingshen ;
Liu, Yufeng .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 51 (03) :200-203
[18]   The Th17/Treg imbalance in patients with acute coronary syndrome [J].
Cheng, Xiang ;
Yu, Xian ;
Ding, Ying-jun ;
Fu, Qing-qing ;
Xie, Jiang-jiao ;
Tang, Ting-ting ;
Yao, Rui ;
Chen, Yong ;
Liao, Yu-hua .
CLINICAL IMMUNOLOGY, 2008, 127 (01) :89-97
[19]   Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study [J].
Choi, HK ;
Hernán, MA ;
Seeger, JD ;
Robins, JM ;
Wolfe, F .
LANCET, 2002, 359 (9313) :1173-1177
[20]   A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism [J].
Coombes, Janine L. ;
Siddiqui, Karima R. R. ;
Arancibia-Carcamo, Carolina V. ;
Hall, Jason ;
Sun, Cheng-Ming ;
Belkaid, Yasmine ;
Powrie, Fiona .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1757-1764